PRA10 RESOURCE UTILIZATION FOR INPATIENT ASTHMA CARE IN CHILDREN AND ADULTS: AN ANALYSIS OF HCUP DATA

Autor: MM Amonkar, MK Hassan

Publikováno v: Value in Health. 5(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4006aba5f7e08482ff76ad0c1c507f02

Clinical Outcomes for Previously Treated Patients with Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Literature Review and Meta-Analysis.

Autor: Abderhalden LA; MSD, Zurich, Switzerland. lauren.abderhalden@msd.com., Wu P; PRECISIONheor, Vancouver, BC, Canada., Amonkar MM; Merck & Co., Inc, Rahway, NJ, USA., Lang BM; MSD, Zurich, Switzerland., Shah S; Merck & Co., Inc, Rahway, NJ, USA., Jin F; Merck & Co., Inc, Rahway, NJ, USA., Frederickson AM; PRECISIONheor, New York, NY, USA., Mojebi A; PRECISIONheor, Vancouver, BC, Canada.

Publikováno v: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2023 Dec; Vol. 54 (4), pp. 1031-1045. Date of Electronic Publication: 2023 May 23.

Clinical outcomes of chemotherapy-based therapies for previously treated advanced colorectal cancer: a systematic literature review and meta-analysis.

Autor: Amonkar MM; Merck & Co., Inc, Rahway, NJ, USA., Abderhalden LA; MSD, Zurich, Switzerland., Frederickson AM; PRECISIONheor, New York, NY, USA., Aksomaityte A; MSD (UK) Limited, London, UK., Lang BM; MSD, Zurich, Switzerland., Leconte P; MSD, Paris, France., Zhang I; PRECISIONheor, New York, NY, USA. ina.zhang@precisionvh.com.

Publikováno v: International journal of colorectal disease [Int J Colorectal Dis] 2023 Jan 11; Vol. 38 (1), pp. 10. Date of Electronic Publication: 2023 Jan 11.

Health-related quality of life in patients treated with pembrolizumab for microsatellite instability-high/mismatch repair-deficient advanced solid tumours: Results from the KEYNOTE-158 study.

Autor: Maio M; Center for Immuno-Oncology, University Hospital of Siena and University of Siena, Siena, Italy. Electronic address: maio@unisi.it., Amonkar MM; Merck & Co., Inc., Rahway NJ, USA. Electronic address: mayur.amonkar@merck.com., Norquist JM; Merck & Co., Inc., Rahway NJ, USA. Electronic address: josephine_norquist@merck.com., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: paolo.ascierto@gmail.com., Manzyuk L; NN Blokhin National Medical Research Center of Oncology, Moscow, Russia. Electronic address: l.manzyuk@gmail.com., Motola-Kuba D; COMOP A.C., Clinical Investigation, Mexico City, Mexico. Electronic address: danielmotola@gmail.com., Penel N; Centre Oscar Lambret and Lille University, Lille, France. Electronic address: n-penel@o-lambret.fr., Cassier PA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France. Electronic address: philippe.cassier@lyon.unicancer.fr., Bariani GM; Instituto Do Câncer Do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil. Electronic address: bariani@yahoo.com., De Jesus Acosta A; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. Electronic address: adejesu1@jhmi.edu., Doi T; National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: doi.toshi@gmail.com., Longo F; Hospital Universitario Ramón y Cajal, IRYCIS, CIBERONC, Madrid, Spain. Electronic address: fedelongomunoz@hotmail.com., Miller WH Jr; Jewish General Hospital and McGill University, Montréal, QC, Canada. Electronic address: wilsonmiller@gmail.com., Oh DY; Department of Internal Medicine, Seoul National University Hospital, and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: ohdoyoun@snu.ac.kr., Gottfried M; Meir Medical Center, Tel Aviv, Israel. Electronic address: maya.gottfried@clalit.org.il., Wang R; Merck & Co., Inc., Rahway NJ, USA. Electronic address: ruixue.wang@merck.com., Norwood K; Merck & Co., Inc., Rahway NJ, USA. Electronic address: kevin.norwood@merck.com., Marabelle A; Gustave Roussy, INSERM U1015 and CIC1418, Université Paris Saclay, Villejuif, France. Electronic address: AURELIEN.MARABELLE@gustaveroussy.fr.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jul; Vol. 169, pp. 188-197. Date of Electronic Publication: 2022 May 16.

Cost and economic burden of adverse events associated with metastatic melanoma treatments in five countries.

Autor: Vouk K; a INC Research GmbH , Munich , Germany ;, Benter U; a INC Research GmbH , Munich , Germany ;, Amonkar MM; b Novartis Pharmaceuticals Corporation , Wayne , PA , USA ;, Marocco A; c Laser Analytica , Milan , Italy ;, Stapelkamp C; d Novartis Pharmaceuticals , London , UK ;, Pfersch S; e Novartis Pharma S.A.S. , Rueil-Malmaison Cedex , France ;, Benjamin L; f GlaxoSmithKline , Marly le Roi Cedex , France.

Publikováno v: Journal of medical economics [J Med Econ] 2016 Sep; Vol. 19 (9), pp. 900-12. Date of Electronic Publication: 2016 May 30.